Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

[Leflunomide and TNF inhibitors. Experiences from precription recourse proceedings].

Brandt-Jürgens J.

Z Rheumatol. 2013 Mar;72(2):114-6. doi: 10.1007/s00393-012-1086-5. German. No abstract available.

PMID:
23223912
2.

[Off-label therapy of rheumatoid arthritis and spondyloarthritis].

Krüger K, Sieper J.

Z Rheumatol. 2012 Feb;71(2):122-4, 126. doi: 10.1007/s00393-011-0903-6. Review. German.

PMID:
22370803
3.

[The rheumatologist's conflict between "off-label" prescription and failure to render assistance].

Hellmich B, Gross WL.

Z Rheumatol. 2003 Feb;62(1):34-5. German. No abstract available.

PMID:
12624800
4.

[Off-label therapy: current problems from the perspective of the Pharmaceutical Commission of the German Medical Profession].

Janzen RW, Ludwig WD; Arzneimittelkommission der deutschen Ärzteschaft, Berlin.

Z Rheumatol. 2012 Feb;71(2):108-10, 112-8. doi: 10.1007/s00393-011-0901-8. Review. German.

PMID:
22370801
5.

[Off-label therapy from the perspective of the medical insurance service].

Grell L, Rieger M.

Z Rheumatol. 2012 Feb;71(2):101-4, 106-7. doi: 10.1007/s00393-011-0900-9. Review. German.

PMID:
22370800
6.

[Off-label therapy in rheumatology].

Krüger K, Sieper J.

Z Rheumatol. 2012 Feb;71(2):99-100. doi: 10.1007/s00393-011-0899-y. German. No abstract available.

PMID:
22370799
7.

[The physician caught between two chairs. Comments on the difficulty in dealing with off-label use].

Harder Yv.

Urologe A. 2007 Oct;46(10):1429-34. German. No abstract available.

PMID:
17786403
8.

Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.

Strangfeld A, Hierse F, Kekow J, von Hinueber U, Tony HP, Dockhorn R, Listing J, Zink A.

Ann Rheum Dis. 2009 Dec;68(12):1856-62. doi: 10.1136/ard.2008.098467. Epub 2009 Jan 6.

PMID:
19126559
9.

[Off-label use of drugs--the legal framework].

Koyuncu A.

Dtsch Med Wochenschr. 2012 Jul;137(30):1519-23. doi: 10.1055/s-0032-1305172. Epub 2012 Aug 6. Review. German. No abstract available.

PMID:
22869512
10.

Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?

Singer O, Gibofsky A.

Curr Opin Rheumatol. 2011 May;23(3):288-92. doi: 10.1097/BOR.0b013e328344f2e4. Review.

PMID:
21378570
11.
12.

[Off-label use in oncology: an inexhaustible topic?!].

Weissbach L, Riese J.

Urologe A. 2006 Nov;45(11):1410, 1412-4. German.

PMID:
17043888
13.

[Leflunomide in combination with TNF-blockers for Methotrexate intolerance].

Krüger K, Manger B; die Kommission Pharmakotherapie der DGRh.

Z Rheumatol. 2009 Mar;68(2):165-8. doi: 10.1007/s00393-008-0422-2. German. No abstract available.

PMID:
19159938
14.

[Solutions for off-label therapy].

Schmidt WA.

Z Rheumatol. 2003;62(Suppl 2):II54-6. German.

PMID:
14648094
15.

Methotrexate and leflunomide combination therapy for patients with active rheumatoid arthritis.

Mroczkowski PJ, Weinblatt ME, Kremer JM.

Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S66-8.

PMID:
10589360
16.

[Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].

Schädlich PK, Zeidler H, Zink A, Gromnica-Ihle E, Schneider M, Straub C, Brecht JG, Huppertz E.

Z Rheumatol. 2004 Feb;63(1):59-75. German.

PMID:
14991279
17.

A licence to cure.

Aronson JK, Ferner RE.

BMJ. 2015 Apr 1;350:h1723. doi: 10.1136/bmj.h1723. No abstract available.

PMID:
25834026
18.

Quality of evidence in drug compendia supporting off-label use of typical and atypical antipsychotic medications.

Paczynski RP, Alexander GC, Chinchilli VM, Kruszewski SP.

Int J Risk Saf Med. 2012 Jan 1;24(3):137-46. doi: 10.3233/JRS-2012-0567.

PMID:
22936056
20.

[Does the decision of the German Constitutional Court signal the end of evidence-based medicine?].

Grell L.

MMW Fortschr Med. 2006 Nov 30;148(48):44. German. No abstract available.

PMID:
17615770
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk